logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cardiovascular Safety In Drug Development And Therapeutic Use New Methodologies And Evolving Regulatory Landscapes 1st Edition J Rick Turner

  • SKU: BELL-5512186
Cardiovascular Safety In Drug Development And Therapeutic Use New Methodologies And Evolving Regulatory Landscapes 1st Edition J Rick Turner
$ 31.00 $ 45.00 (-31%)

4.3

98 reviews

Cardiovascular Safety In Drug Development And Therapeutic Use New Methodologies And Evolving Regulatory Landscapes 1st Edition J Rick Turner instant download after payment.

Publisher: Adis
File Extension: PDF
File size: 3.76 MB
Pages: 333
Author: J. Rick Turner, Dilip R. Karnad, Snehal Kothari
ISBN: 9783319403458, 3319403451
Language: English
Year: 2016
Edition: 1

Product desciption

Cardiovascular Safety In Drug Development And Therapeutic Use New Methodologies And Evolving Regulatory Landscapes 1st Edition J Rick Turner by J. Rick Turner, Dilip R. Karnad, Snehal Kothari 9783319403458, 3319403451 instant download after payment.

At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future.  Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, and the Comprehensive in vitro Proarrhythmia Assay initiative is well under way.

Developments in the field of cardiovascular safety are also described and discussed in the book.  These include the search for more efficient ways to exonerate new drugs for type 2 diabetes from an unacceptable cardiovascular liability, how best to address off-target blood pressure increases induced by noncardiovascular drugs, and the continued evolution of the discipline of Cardio-oncology.

Related Products